ATLANTA, GA, Neurofenix, the neurological rehabilitation platform that uses sensors to improve patient outcomes, has raised $7 million in Series A funding.
This funding was led by AlbionVC, with additional participation by HTH, InHealth Ventures, and existing investors. This will enable Neurofenix to build out its product line and invest in US expansion, including funding US clinical trials.
Neurofenix is an innovative digital therapeutics company empowering patients and their families to get their life back after suffering a stroke, traumatic brain injury or spinal cord injury.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
